Skip to content

Sleeve Gastrectomy and the Influence of Concomitant Hiatal Hernia Repair

Sleeve Gastrectomy and the Influence of Concomitant Hiatal Hernia Repair - Sleeve Gastrectomy and Concomitant Hiatal Hernia Repair

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42404
Enrollment
80
Registered
2016-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

excess stomach acid GERD

Interventions

All 80 patients will undergo an additional pre-operative and three and 12 months postoperative combined pH-impedance and high-resolution manometry (HRM) examination in addition to the standard pre-a

Sponsors

Sint Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 18-65 years - Body Mass Index (BMI) of *40 or *35 with significant comorbidity, with an indication for LSG - Fit for surgery

Exclusion criteria

Exclusion criteria: - Age 65 years - No informed consent - History of GERD, reflux esophagitis or Barrett*s esophagus - History of, or intraoperatively diagnosed, paraesophageal hernia (type II) or mixed (type III), or hiatal hernia > 5,0 cm - Previous anti-reflux surgery, HH repair or previous bariatric surgery - Pregnant - Severe esophageal motility disorders

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the differences in total esophageal acid exposure between patients (diagnosed with small HH) who underwent either LSG alone or LSG+HHR.

Secondary

MeasureTime frame
Secondary endpoints consist of 1) changes in prevalence and intensity of GERD symptoms, dysphagia symptoms, and quality of life based on validated questionnaires between these two groups, 2) changes in belching, the number of acid and weakly acidic reflux episodes and manometric changes, 3) the effect of LSG on total esophageal acid exposure, weakly acid exposure and manometric changes in patients with no intraoperatively diagnosed HH who underwent LSG alone and (4) changes in anti-reflux medication usage in both groups of patients within the HH-group and patients in the no-HH-group.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)